Crossmark

A preliminary exploration of a predictive model and nomogram for the efficacy of compound digestive enzyme therapy based on serum (PGI, PGII, VIP, and PRDX1) in patients with functional dyspepsia

Crossref DOI link: https://doi.org/10.1186/s12876-025-04024-5

Published Online: 2025-05-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pan, Jiachao

Zhang, Bo

Ren, Wenqiang
License Information

Text and Data Mining valid from 2025-05-28

Version of Record valid from 2025-05-28
More Information

Article History

Received: 6 March 2025

Accepted: 22 May 2025

First Online: 28 May 2025

Declarations

:

: The study was approved by the Ethics Committee of The Central Hospital Affiliated to Shandong First Medical University (No. 2022JCH-021532), and informed consent was obtained from all patients. This study was conducted in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below